BrightGene Historical Balance Sheet

688166 Stock

30.92 1.21 4.07%

Trend analysis of BrightGene Bio Medical balance sheet accounts such as Other Current Liab of 26.6 M, Total Current Liabilities of 1.1 B or Total Stockholder Equity of 1.4 B provides information on BrightGene Bio's total assets, liabilities, and equity, which is the actual value of BrightGene Bio Medical to its prevalent stockholders. By breaking down trends over time using BrightGene Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

BrightGene Bio Inventory

416.14 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightGene Bio Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About BrightGene Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of BrightGene Bio Medical at a specified time, usually calculated after every quarter, six months, or one year. BrightGene Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BrightGene Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BrightGene currently owns. An asset can also be divided into two categories, current and non-current.

BrightGene Bio Balance Sheet Chart

At present, BrightGene Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 26.6 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of BrightGene Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BrightGene Bio Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on BrightGene Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BrightGene Bio Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from BrightGene Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BrightGene Bio Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightGene Bio Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	50.7M	20.1M	18.1M	26.6M
Total Assets	4.7B	5.0B	5.8B	6.1B

Other Current Liab Total Assets

BrightGene Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Liab	Common Stock Shares Outstanding	Net Invested Capital	Net Working Capital
Total Assets		-0.5	0.98	0.9	0.88	1.0	0.98	0.97	0.99	0.56	0.98	0.85	0.01	0.99	0.85	0.98	0.76	0.71	0.9	0.97	0.8	0.99	0.75	0.83	1.0	0.83
Other Current Liab	-0.5		-0.48	-0.52	-0.49	-0.52	-0.43	-0.4	-0.51	-0.25	-0.46	-0.48	-0.16	-0.56	-0.23	-0.45	-0.43	0.01	-0.44	-0.52	-0.54	-0.45	-0.4	-0.55	-0.47	-0.35
Total Current Liabilities	0.98	-0.48		0.84	0.81	0.97	0.98	0.92	0.99	0.52	0.96	0.8	-0.15	0.96	0.84	1.0	0.71	0.65	0.84	0.98	0.72	0.99	0.64	0.75	0.98	0.73
Total Stockholder Equity	0.9	-0.52	0.84		1.0	0.92	0.87	0.9	0.87	0.67	0.88	0.93	0.22	0.9	0.88	0.84	0.86	0.72	0.99	0.87	0.94	0.87	0.89	0.94	0.9	0.92
Net Tangible Assets	0.88	-0.49	0.81	1.0		0.9	0.86	0.88	0.85	0.68	0.86	0.94	0.24	0.87	0.88	0.81	0.86	0.74	0.98	0.86	0.95	0.85	0.9	0.95	0.88	0.92
Retained Earnings	1.0	-0.52	0.97	0.92	0.9		0.98	0.95	0.99	0.61	0.97	0.88	0.06	0.99	0.86	0.97	0.8	0.72	0.91	0.98	0.83	0.98	0.79	0.86	0.99	0.83
Accounts Payable	0.98	-0.43	0.98	0.87	0.86	0.98		0.92	0.98	0.52	0.94	0.89	-0.12	0.94	0.91	0.97	0.72	0.77	0.87	0.98	0.78	0.99	0.71	0.81	0.98	0.76
Cash	0.97	-0.4	0.92	0.9	0.88	0.95	0.92		0.94	0.55	0.95	0.79	0.13	0.95	0.81	0.94	0.73	0.74	0.93	0.89	0.81	0.94	0.77	0.83	0.97	0.92
Non Current Assets Total	0.99	-0.51	0.99	0.87	0.85	0.99	0.98	0.94		0.54	0.97	0.83	-0.06	0.98	0.85	0.99	0.73	0.68	0.87	0.98	0.76	1.0	0.7	0.79	0.99	0.77
Non Currrent Assets Other	0.56	-0.25	0.52	0.67	0.68	0.61	0.52	0.55	0.54		0.69	0.54	0.34	0.63	0.59	0.49	0.9	0.48	0.63	0.62	0.72	0.51	0.63	0.72	0.57	0.61
Other Assets	0.98	-0.46	0.96	0.88	0.86	0.97	0.94	0.95	0.97	0.69		0.79	0.05	0.98	0.84	0.96	0.81	0.69	0.88	0.96	0.79	0.96	0.71	0.82	0.98	0.81
Net Receivables	0.85	-0.48	0.8	0.93	0.94	0.88	0.89	0.79	0.83	0.54	0.79		0.08	0.82	0.91	0.78	0.78	0.8	0.89	0.87	0.9	0.85	0.86	0.9	0.85	0.78
Short Term Investments	0.01	-0.16	-0.15	0.22	0.24	0.06	-0.12	0.13	-0.06	0.34	0.05	0.08		0.1	-0.11	-0.12	0.26	0.15	0.19	-0.07	0.26	-0.08	0.46	0.25	0.01	0.34
Inventory	0.99	-0.56	0.96	0.9	0.87	0.99	0.94	0.95	0.98	0.63	0.98	0.82	0.1		0.79	0.96	0.8	0.65	0.89	0.96	0.81	0.97	0.77	0.84	0.98	0.82
Other Current Assets	0.85	-0.23	0.84	0.88	0.88	0.86	0.91	0.81	0.85	0.59	0.84	0.91	-0.11	0.79		0.84	0.73	0.86	0.88	0.88	0.8	0.88	0.69	0.8	0.86	0.74
Total Liab	0.98	-0.45	1.0	0.84	0.81	0.97	0.97	0.94	0.99	0.49	0.96	0.78	-0.12	0.96	0.84		0.68	0.66	0.85	0.96	0.7	0.99	0.64	0.73	0.98	0.76
Deferred Long Term Liab	0.76	-0.43	0.71	0.86	0.86	0.8	0.72	0.73	0.73	0.9	0.81	0.78	0.26	0.8	0.73	0.68		0.56	0.82	0.79	0.89	0.71	0.85	0.89	0.77	0.78
Short Long Term Debt	0.71	0.01	0.65	0.72	0.74	0.72	0.77	0.74	0.68	0.48	0.69	0.8	0.15	0.65	0.86	0.66	0.56		0.73	0.7	0.68	0.73	0.68	0.69	0.73	0.69
Total Current Assets	0.9	-0.44	0.84	0.99	0.98	0.91	0.87	0.93	0.87	0.63	0.88	0.89	0.19	0.89	0.88	0.85	0.82	0.73		0.85	0.91	0.87	0.85	0.91	0.91	0.95
Intangible Assets	0.97	-0.52	0.98	0.87	0.86	0.98	0.98	0.89	0.98	0.62	0.96	0.87	-0.07	0.96	0.88	0.96	0.79	0.7	0.85		0.79	0.98	0.71	0.82	0.97	0.73
Common Stock	0.8	-0.54	0.72	0.94	0.95	0.83	0.78	0.81	0.76	0.72	0.79	0.9	0.26	0.81	0.8	0.7	0.89	0.68	0.91	0.79		0.75	0.88	1.0	0.81	0.89
Property Plant Equipment	0.99	-0.45	0.99	0.87	0.85	0.98	0.99	0.94	1.0	0.51	0.96	0.85	-0.08	0.97	0.88	0.99	0.71	0.73	0.87	0.98	0.75		0.69	0.78	0.99	0.77
Other Liab	0.75	-0.4	0.64	0.89	0.9	0.79	0.71	0.77	0.7	0.63	0.71	0.86	0.46	0.77	0.69	0.64	0.85	0.68	0.85	0.71	0.88	0.69		0.88	0.75	0.86
Common Stock Shares Outstanding	0.83	-0.55	0.75	0.94	0.95	0.86	0.81	0.83	0.79	0.72	0.82	0.9	0.25	0.84	0.8	0.73	0.89	0.69	0.91	0.82	1.0	0.78	0.88		0.83	0.89
Net Invested Capital	1.0	-0.47	0.98	0.9	0.88	0.99	0.98	0.97	0.99	0.57	0.98	0.85	0.01	0.98	0.86	0.98	0.77	0.73	0.91	0.97	0.81	0.99	0.75	0.83		0.84
Net Working Capital	0.83	-0.35	0.73	0.92	0.92	0.83	0.76	0.92	0.77	0.61	0.81	0.78	0.34	0.82	0.74	0.76	0.78	0.69	0.95	0.73	0.89	0.77	0.86	0.89	0.84

Click cells to compare fundamentals

BrightGene Bio Account Relationship Matchups

BrightGene Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8B	3.0B	4.7B	5.0B	5.8B	6.1B
Other Current Liab	32.0M	25.9M	50.7M	20.1M	18.1M	26.6M
Total Current Liabilities	291.7M	583.1M	811.5M	922.2M	1.1B	1.1B
Total Stockholder Equity	1.4B	1.7B	2.2B	2.4B	2.7B	1.4B
Net Tangible Assets	1.3B	1.4B	1.6B	2.1B	2.4B	1.2B
Retained Earnings	345.5M	555.1M	743.4M	830.4M	955.0M	1.0B
Accounts Payable	79.6M	211.9M	252.2M	228.2M	262.4M	275.5M
Cash	339.5M	336.8M	1.2B	998.0M	1.1B	1.2B
Non Current Assets Total	881.4M	2.0B	2.7B	3.2B	3.7B	3.9B
Non Currrent Assets Other	628.5M	115.9M	300.9M	233.3M	268.3M	184.6M
Other Assets	56.8M	223.3M	161.5M	351.7M	404.5M	424.7M
Net Receivables	177.3M	373.3M	302.8M	283.0M	325.4M	224.4M
Non Current Liabilities Total	103.5M	644.9M	1.6B	1.7B	1.9B	2.0B
Inventory	203.2M	200.1M	280.4M	344.6M	396.3M	416.1M
Other Current Assets	39.6M	73.3M	95.4M	65.2M	75.0M	49.4M
Total Liab	395.2M	1.2B	2.4B	2.6B	3.0B	3.2B
Deferred Long Term Liab	22.9M	33.0M	25.8M	26.9M	30.9M	26.2M
Total Current Assets	946.4M	993.0M	1.9B	1.8B	2.1B	1.1B
Intangible Assets	48.8M	80.8M	81.6M	93.7M	107.7M	113.1M
Property Plant Equipment	244.7M	452.5M	1.4B	2.1B	2.4B	2.5B
Net Invested Capital	1.7B	2.6B	4.2B	4.1B	4.8B	5.0B
Net Working Capital	654.7M	409.9M	1.1B	917.5M	1.1B	745.5M
Other Stockholder Equity	(7.2M)	(24.8M)	(25.8M)	17.8M	20.4M	21.5M
Property Plant And Equipment Net	452.5M	1.4B	2.1B	2.5B	2.9B	1.5B
Property Plant And Equipment Gross	577.3M	1.5B	2.1B	2.7B	3.1B	1.6B

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

Other Information on Investing in BrightGene Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BrightGene Historical Balance Sheet

BrightGene Bio Inventory

416.14 Million

About BrightGene Balance Sheet Analysis

BrightGene Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

BrightGene Bio balance sheet Correlations

BrightGene Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BrightGene Bio balance sheet Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in BrightGene Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Property Plant Equipment	+ 1.0	Non Current Assets Total
Common Stock Shares Outstanding	+ 1.0	Common Stock

Inventory	- 0.56	Other Current Liab
Common Stock Shares Outstanding	- 0.55	Other Current Liab
Common Stock	- 0.54	Other Current Liab
Intangible Assets	- 0.52	Other Current Liab
Retained Earnings	- 0.52	Other Current Liab
Total Stockholder Equity	- 0.52	Other Current Liab